Duftner Christina, Dejaco Christian, Sepriano Alexandre, Falzon Louise, Schmidt Wolfgang Andreas, Ramiro Sofia
Department of Internal Medicine, Clinical Division of Internal Medicine II, Medical University Innsbruck, Innsbruck, Austria.
Rheumatology Service, South Tyrolean Health Trust, Hospital of Bruneck, Bruneck, Italy.
RMD Open. 2018 Feb 2;4(1):e000612. doi: 10.1136/rmdopen-2017-000612. eCollection 2018.
To perform a systematic literature review on imaging techniques for diagnosis, outcome prediction and disease monitoring in large vessel vasculitis (LVV) informing the European League Against Rheumatism recommendations for imaging in LVV.
Systematic literature review (until 10 March 2017) of diagnostic and prognostic studies enrolling >20 patients and investigating ultrasound, MRI, CT or positron emission tomography (PET) in patients with suspected and/or established primary LVV. Meta-analyses were conducted, whenever possible, obtaining pooled estimates for sensitivity and specificity by fitting random effects models.
Forty-three studies were included (39 on giant cell arteritis (GCA), 4 on Takayasu arteritis (TAK)). Ultrasound ('halo' sign) at temporal arteries (8 studies, 605 patients) and MRI of cranial arteries (6 studies, 509 patients) yielded pooled sensitivities of 77% (95% CI 62% to 87%) and 73% (95% CI 57% to 85%), respectively, compared with a clinical diagnosis of GCA. Corresponding specificities were 96% (95% CI 85% to 99%) and 88% (95% CI 81% to 92%). Two studies (93 patients) investigating PET for GCA diagnosis reported sensitivities of 67%-77% and specificities of 66%-100% as compared with clinical diagnosis or temporal artery biopsy. In TAK, one study each evaluated the role of magnetic resonance angiography and CT angiography for diagnostic purposes revealing both a sensitivity and specificity of 100%. Studies on outcome prediction and monitoring disease activity/damage were limited and mainly descriptive.
Ultrasound and MRI provide a high diagnostic value for cranial GCA. More data on the role of imaging for diagnosis of extracranial large vessel GCA and TAK, as well as for outcome prediction and monitoring in LVV are warranted.
对大血管血管炎(LVV)的诊断、预后预测和疾病监测的成像技术进行系统的文献综述,为欧洲抗风湿病联盟关于LVV成像的建议提供依据。
对纳入超过20例患者的诊断和预后研究进行系统文献综述(截至2017年3月10日),调查疑似和/或确诊的原发性LVV患者的超声、MRI、CT或正电子发射断层扫描(PET)。尽可能进行荟萃分析,通过拟合随机效应模型获得敏感性和特异性的合并估计值。
纳入43项研究(39项关于巨细胞动脉炎(GCA),4项关于大动脉炎(TAK))。与GCA的临床诊断相比,颞动脉超声(“晕轮”征)(8项研究,605例患者)和颅动脉MRI(6项研究,509例患者)的合并敏感性分别为77%(95%CI 62%至87%)和73%(95%CI 57%至85%)。相应的特异性分别为96%(95%CI 85%至99%)和88%(95%CI 81%至92%)。两项研究(93例患者)调查PET用于GCA诊断,与临床诊断或颞动脉活检相比,报告的敏感性为67%-77%,特异性为66%-100%。在TAK中,各有一项研究评估了磁共振血管造影和CT血管造影在诊断中的作用,显示敏感性和特异性均为100%。关于预后预测和监测疾病活动/损伤的研究有限,主要为描述性研究。
超声和MRI对颅部GCA具有较高的诊断价值。需要更多关于成像在颅外大血管GCA和TAK诊断中的作用以及在LVV预后预测和监测中的作用的数据。